{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:31:49Z","timestamp":1786991509225,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jaut.2021.102597","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T19:05:26Z","timestamp":1611342326000},"page":"102597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis"],"prefix":"10.1016","volume":"118","author":[{"given":"Felix I.L.","family":"Clanchy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Borghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Bystrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Balog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Penn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dobrina N.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham M.A.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serafim","family":"Kiriakidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.","family":"Sacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizgar A.","family":"Mageed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard O.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2021.102597_bib1","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1002\/art.24140","article-title":"Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis","volume":"58","author":"Ospelt","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102597_bib2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4049\/jimmunol.1102977","article-title":"TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-alpha levels","volume":"189","author":"Chamberlain","year":"1950","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102597_bib3","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/art.10848","article-title":"Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling","volume":"48","author":"Kyburz","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102597_bib4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0002-9440(10)63918-1","article-title":"Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium","volume":"162","author":"Seibl","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2021.102597_bib5","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/art.20219","article-title":"Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis","volume":"50","author":"Iwahashi","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102597_bib6","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1002\/art.20678","article-title":"Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma","volume":"50","author":"Radstake","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102597_bib7","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/art.21278","article-title":"The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7\/8 results in synergistic cytokine production by dendritic cells","volume":"52","author":"Roelofs","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102597_bib8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/annrheumdis-2011-201203","article-title":"Ligation of TLR7 by rheumatoid arthritis synovial fluid single strand RNA induces transcription of TNF\u03b1 in monocytes","volume":"72","author":"Chamberlain","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102597_bib9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/1529-0131(199906)42:6<1109::AID-ANR7>3.0.CO;2-7","article-title":"Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression","volume":"42","author":"Thornton","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102597_bib10","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar3774","article-title":"Cytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators?","volume":"14","author":"Paquet","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2021.102597_bib11","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2353\/ajpath.2010.100195","article-title":"Characterization of the KRN cell transfer model of rheumatoid arthritis (KRN-CTM), a chronic yet synchronized version of the K\/BxN mouse","volume":"177","author":"LaBranche","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2021.102597_bib12","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar3875","article-title":"Investigation of the role of endosomal Toll-like receptors in murine collagen-induced arthritis reveals a potential role for TLR7 in disease maintenance","volume":"14","author":"Alzabin","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2021.102597_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1749-6632.2009.04849.x","article-title":"Toll-like receptors in multiple sclerosis mouse experimental models","volume":"1173","author":"Marta","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2021.102597_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023539","article-title":"Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collagen-induced arthritis in DBA1J mice","volume":"6","author":"Pierer","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2021.102597_bib15","doi-asserted-by":"crossref","first-page":"e11484","DOI":"10.1371\/journal.pone.0011484","article-title":"Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice","volume":"5","author":"Aumeunier","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2021.102597_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075385","article-title":"Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice","volume":"8","author":"G\u00fclden","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2021.102597_bib17","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.1001388","article-title":"Inhibition of autoimmune diabetes by TLR2 tolerance","volume":"187","author":"Kim","year":"1950","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102597_bib18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3920\/BM2017.0194","article-title":"Regulatory T cells and Toll-like receptor 2 and 4 mRNA expression in infants with colic treated with Lactobacillus reuteri DSM17938","volume":"9","author":"Savino","year":"2018","journal-title":"Benef. Microbes"},{"key":"10.1016\/j.jaut.2021.102597_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fcimb.2013.00052","article-title":"Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation","volume":"3","author":"Ray","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jaut.2021.102597_bib20","first-page":"265","article-title":"Collagen-induced arthritis in mice: a major role for tumor necrosis factor-alpha","volume":"361","author":"Williams","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jaut.2021.102597_bib21","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.4049\/jimmunol.161.7.3639","article-title":"Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice","volume":"161","author":"Campbell","year":"1950","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102597_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(89)90430-3","article-title":"Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis","volume":"2","author":"Brennan","year":"1989","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jaut.2021.102597_bib23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2144\/03342mt01","article-title":"TM4: a free, open-source system for microarray data management and analysis","volume":"34","author":"Saeed","year":"2003","journal-title":"Biotechniques"},{"key":"10.1016\/j.jaut.2021.102597_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/icb.1994.55","article-title":"Effects of the anti-inflammatory compounds castanospermine, mannose-6-phosphate and fucoidan on allograft rejection and elicited peritoneal exudates","volume":"72","author":"Bartlett","year":"1994","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jaut.2021.102597_bib25","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1517\/14712598.2010.534080","article-title":"Modulation of toll-like receptor function has therapeutic potential in autoimmune disease","volume":"10","author":"Clanchy","year":"2010","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.jaut.2021.102597_bib26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/10409238.2015.1033511","article-title":"Advances in Toll-like receptor biology: modes of activation by diverse stimuli","volume":"50","author":"Bryant","year":"2015","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.jaut.2021.102597_bib27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1189\/jlb.1111566","article-title":"Kupffer cells express a unique combination of phenotypic and functional characteristics compared with splenic and peritoneal macrophages","volume":"92","author":"Movita","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2021.102597_bib28","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1175202","article-title":"Identification of splenic reservoir monocytes and their deployment to inflammatory sites","volume":"325","author":"Swirski","year":"2009","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jaut.2021.102597_bib29","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1136\/annrheumdis-2011-201024","article-title":"Incomplete response of inflammatory arthritis to TNFalpha blockade is associated with the Th17 pathway","volume":"71","author":"Alzabin","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102597_bib30","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(08)61452-X","article-title":"Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease","volume":"372","author":"Anderson","year":"2008","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jaut.2021.102597_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12016-017-8610-y","article-title":"Response to treatment with TNFalpha inhibitors in rheumatoid arthritis is associated with high levels of GM-CSF and GM-CSF(+) T lymphocytes","volume":"53","author":"Bystrom","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2021.102597_bib32","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102597_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/jir.2015.0060","article-title":"High-affinity Fc receptor expression indicates relative immaturity in human monocytes","volume":"36","author":"Clanchy","year":"2016","journal-title":"J. Interferon Cytokine Res. : the official journal of the International Society for Interferon and Cytokine Research"},{"key":"10.1016\/j.jaut.2021.102597_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000107","article-title":"A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2","volume":"4","author":"Chang","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jaut.2021.102597_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00296-013-2666-7","article-title":"Toll-like receptor polymorphisms and rheumatoid arthritis: a systematic review","volume":"34","author":"Lee","year":"2014","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2021.102597_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21111529","article-title":"Recent progress in the molecular recognition and therapeutic importance of interleukin-1 receptor-associated Kinase 4","volume":"21","author":"Patra","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.jaut.2021.102597_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.prp.2014.11.001","article-title":"Association of Toll like receptor Asp299Gly with rheumatoid arthritis risk: a systematic review of case-control studies and meta-analysis","volume":"211","author":"Tizaoui","year":"2015","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.jaut.2021.102597_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jaut.2021.102597_bib39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s10875-015-0182-0","article-title":"Paradoxical expansion of Th1 and Th17 lymphocytes in rheumatoid arthritis following infliximab treatment: a possible explanation for a lack of clinical response","volume":"35","author":"Talotta","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102597_bib40","doi-asserted-by":"crossref","first-page":"30594","DOI":"10.1038\/srep30594","article-title":"Role of the gut microbiome in modulating arthritis progression in mice","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2021.102597_bib41","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.immuni.2010.06.001","article-title":"Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells","volume":"32","author":"Wu","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102597_bib42","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1074\/jbc.M109.038331","article-title":"The anti-apoptotic protein BCL2L1\/Bcl-xL is neutralized by pro-apoptotic PMAIP1\/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression","volume":"285","author":"Hagenbuchner","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2021.102597_bib43","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.182.3.1746","article-title":"Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer","volume":"182","author":"Tan","year":"1950","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102597_bib44","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1002\/art.23363","article-title":"Anticytokine treatment of established type II collagen-induced arthritis in DBA\/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha\/beta and IL-1Ra","volume":"58","author":"Joosten","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102597_bib45","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.4049\/jimmunol.167.2.1004","article-title":"IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis","volume":"167","author":"Lubberts","year":"1950","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102597_bib46","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1002\/art.22848","article-title":"Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis","volume":"56","author":"Abdollahi-Roodsaz","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102597_bib47","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3899\/jrheum.080169","article-title":"Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1beta and IL-6 production in autoimmune arthritis","volume":"36","author":"Lee","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102597_bib48","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm.1987","article-title":"Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease","volume":"15","author":"Midwood","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2021.102597_bib49","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/annrheumdis-2018-214294","article-title":"Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?","volume":"78","author":"Aungier","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102597_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13075-015-0901-1","article-title":"Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists","volume":"18","author":"Lacerte","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2021.102597_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/132732","article-title":"Increased responsiveness to toll-like receptor 4 stimulation in peripheral blood mononuclear cells from patients with recent onset rheumatoid arthritis","author":"Kowalski","year":"2008","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jaut.2021.102597_bib52","first-page":"958","article-title":"Toll-like receptor (TLR) 2 is upregulated on peripheral blood monocytes of patients with psoriatic arthritis: a role for a gram-positive inflammatory trigger?","volume":"29","author":"Carrasco","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102597_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109775","article-title":"Functional phenotype of synovial monocytes modulating inflammatory T-cell responses in rheumatoid arthritis (RA)","volume":"9","author":"Yoon","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2021.102597_bib54","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/rheumatology\/keq362","article-title":"Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis","volume":"50","author":"Myles","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2021.102597_bib55","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/rheumatology\/kep293","article-title":"Investigating the role of the interleukin-23\/-17A axis in rheumatoid arthritis","volume":"48","author":"Hillyer","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2021.102597_bib56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fmed.2020.00021","article-title":"New developments in transcriptomic analysis of synovial tissue","volume":"7","author":"Carr","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2021.102597_bib57","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat. Immunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:26:08Z","timestamp":1760257568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841121000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":57,"alternative-id":["S0896841121000056"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102597","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102597"}}